StockWatch
·
Medical Specialities
Business UpdateJun 1, 2026, 06:42 AM

Humana Reaffirms FY 2026 EPS Guidance: GAAP at least $8.36, Adj. $9.00

AI Summary

Humana Inc. announced that its senior management will meet with investors and analysts throughout June 2026. During these meetings, the company intends to reaffirm its full-year 2026 guidance. This includes diluted earnings per common share (GAAP) of at least $8.36 and adjusted earnings per common share (non-GAAP) of at least $9.00, consistent with previous guidance.

Key Highlights

  • Humana reaffirms FY 2026 diluted EPS (GAAP) guidance of at least $8.36.
  • Humana reaffirms FY 2026 adjusted EPS (non-GAAP) guidance of at least $9.00.
  • Adjusted EPS includes $0.30 for amortization of identifiable intangibles.
  • Adjusted EPS includes $(0.28) for put/call valuation adjustments.
  • Adjusted EPS includes $0.81 for value creation initiatives.
  • Adjusted EPS includes $(0.19) for cumulative net tax impact.
  • Company expects potential changes to GAAP EPS due to strategic initiatives.